Cargando…
Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia
BACKGROUND: Altered metabolism is a hallmark of cancer. However, the role of genomic changes in metabolic genes driving the tumour metabolic shift remains to be elucidated. Here, we have investigated the genomic and transcriptomic changes underlying this shift across ten different cancer types. RESU...
Autores principales: | Haider, Syed, McIntyre, Alan, van Stiphout, Ruud G. P. M., Winchester, Laura M., Wigfield, Simon, Harris, Adrian L., Buffa, Francesca M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4926297/ https://www.ncbi.nlm.nih.gov/pubmed/27358048 http://dx.doi.org/10.1186/s13059-016-0999-8 |
Ejemplares similares
-
Carbonic anhydrase IX induction defines a heterogeneous cancer cell response to hypoxia and mediates stem cell-like properties and sensitivity to HDAC inhibition
por: Ledaki, Ioanna, et al.
Publicado: (2015) -
Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis
por: Jubb, Adrian M, et al.
Publicado: (2010) -
Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer
por: Morotti, Matteo, et al.
Publicado: (2019) -
The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer
por: da Motta, L L, et al.
Publicado: (2017) -
Pan-cancer characterisation of microRNA across cancer hallmarks reveals microRNA-mediated downregulation of tumour suppressors
por: Dhawan, Andrew, et al.
Publicado: (2018)